Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis (Q35814373)

10 August 2017

Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis (English)

1 reference

Cytomegalovirus encephalitis

10 August 2017

1 reference

1 reference

Hengge UR

1

1 reference

10 August 2017

Brockmeyer NH

2

1 reference

10 August 2017

Malessa R

3

1 reference

10 August 2017

Ravens U

4

1 reference

10 August 2017

Goos M

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 1993

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

37

1 reference

10 August 2017

5

1 reference

10 August 2017

1010-1014

1 reference

Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Value of necropsy in acquired immunodeficiency syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Multifocal cytomegalovirus encephalitis in AIDS.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Foscarnet therapy of cytomegalovirus retinitis in AIDS.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Central nervous system side effects of ganciclovir.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Cytomegalovirus encephalitis in a non-immunocompromised patient: CSF diagnosis byin situhybridization cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Human pharmacokinetics of the antiviral drug DHPG.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187882

Immunochemical estimation of IgG and albumin in cerebrospinal fluid

24 September 2018

1 reference

12 December 2020

Central nervous system vasculitis in cytomegalovirus infection

1 reference

12 December 2020

Widespread presence of histologically occult cytomegalovirus

1 reference

12 December 2020

Progressive polyradiculopathy in acquired immune deficiency syndrome

1 reference

12 December 2020

Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome

1 reference

12 December 2020

Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus

1 reference

12 December 2020

Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatography

1 reference

12 December 2020

Regression of cauda equina syndrome in AIDS patient being treated with ganciclovir

1 reference

12 December 2020

Reversible inhibition of cytomegalovirus replication by phosphonoformate

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.37.5.1010

1 reference

10 August 2017

1 reference

10 August 2017

1 reference